Related Experiment Videos

Pneumatosis intestinalis in an infant undergoing bone marrow transplantation for Wiskott-Aldrich syndrome

D Uçkan1, M Cetin, M Haliloglu

  • 1Bone Marrow Transplantation Unit, Ihsan Dogramaci Children's Hospital, Hacettepe University, Yenisehir 06100, Ankara, Turkey. duckan@gen.hun.edu.tr

Pediatric Transplantation
|September 19, 2001
PubMed

Insights

Pneumatosis intestinalis (PI) is a rare complication following bone marrow transplantation (BMT) in infants with Wiskott-Aldrich syndrome (WAS). This case highlights potential contributing factors and the critical condition of the patient.

Area of Science:

  • Immunology
  • Gastroenterology
  • Pediatric Hematology

Background:

  • Wiskott-Aldrich syndrome (WAS) is a rare X-linked immunodeficiency disorder.
  • Bone marrow transplantation (BMT) is a curative therapy for WAS.
  • Pneumatosis intestinalis (PI) is a known complication in immunocompromised patients.

Observation:

  • A 7-month-old infant with WAS developed PI post-BMT.
  • The patient received a human leucocyte antigen (HLA)-matched paternal bone marrow transplant.
  • Contributing factors may include mucosal damage, conditioning regimen, immunosuppression, neutropenia, and infection.

Findings:

  • PI resolved with conservative management.
  • The patient experienced severe post-transplant complications including Klebsiella pneumonia sepsis and interstitial pneumonitis.
  • The patient ultimately failed engraftment and died on day +66.

Implications:

  • This is the first reported case of PI in a patient with WAS.
  • Early recognition and management of PI in post-BMT patients are crucial.
  • Further research is needed to understand the specific risks and mechanisms of PI in WAS patients undergoing BMT.

Related Concept Videos